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Abstract
This report describes the typical manifestations of chloroquine retinopathy with some advanced new technology. A
series of examinations were performed on the patients, including the fundus fluorescein angiography, optical
coherence tomography, GDxVCC Nerve Fiber Analyzer, full-field electroretinography, multifocal electroretinography
and visual field examinations, to provide a better understanding of chloroquine retinopathy.
Introduction
Chloroquine has long been used in the treatment and
prevention of malaria[1-4], and for a long time, the agent
is still being used to treat other diseases. For example,
due to its immunosuppressive effects, chloroquine has
been used in the treatment of autoimmune disorders,
such as rheumatoid arthritis and lupus erythematosus.
Chloroquine has also been tested in clinical trials as an
antiretroviral agent against HIV [5] and as a radiosensiti-
zer and chemosensitizer for human cancer therapy [6].
However, the side effects of Chloroquine, including ocu-
lar toxicities, limit its long-term use [2-4,6].
Herein we describe two patients who developed severe
ocular toxicity following long-term chloroquine treatment.
The clinical characteristics of their retinopathy were
extensively investigated using various techniques, and are
reported in this manuscript. We are not trying to provide
information which would help in the early screening for
chloroquine retinopathy, but to describe the typical mani-
festations of chloroquine retinopathy with some advanced
new technology which have not been applied on this dis-
ease before, believing that it would provide a better under-
standing of chloroquine retinopathy.
Case Reports
Case 1
A 43-year-old woman had taken chloroquine for her
rheumatoid arthritis for 16 years, and had received a
total dose of approximately 800 g of the drug (250 mg
daily for two years, then 250 mg alternative daily for 14
years). Her visual acuity had decreased gradually during
the previous 5 years. At her latest examination, her
visual acuity was 20/100 OD and hand motions OS,
Goldmann applanation intraocular pressure was normal
(OD16 mmHg, OS 16 mmHg), but the center visual
field (10-2 Humphrey Visual Field Analyzer, Humphrey
Instruments Inc, San Leandro, Calif) was lost, and the
Goldmann visual field showed a temporal visual island.
Photography of her ocular fundus showed pigmentary
deposits and atrophy, attenuation of the retinal artery,
waxy pallor of the optic disc, and retinal atrophy (Figure
1 Part A). Fundus fluorescein angiography (FFA) showed
a marked window defect in the macular area, blocked
fluorescence in the central fovea, and dispersed blocked
fluorescence dots in the peripheral retina (Figure 1 Part
B), but the shape and the boundary of the lesion in the
macula area were not so clear, compared to the pictures
shown in the textbook or other reports. The optical
coherence tomography (OCT, Cirrus HD OCT, SW
Ver:3.0.0.64, Carl Zeiss Meditec, Inc. Germany) indi-
cated obvious thinning of the macula and the prolifera-
tion of the retinal pigment epithelium (RPE) in the
central fovea with adjacent RPE atrophy (Figure 2 Part
A). In addition, the RPE signal was irregular (Figure 2
Part B). The retinal nerve fiber layer (RNFL) thickness
around the optic nerve measured by OCT was normal
(figure not shown). Additionally, examination using a
GDxVCC Nerve Fiber Analyzer (Carl Zeiss Meditec,
Dublin, CA, USA) showed no abnormality of the RNFL
* Correspondence: maxiaoy1820@tom.com
1Department of Ophthalmology, Guanghua Rheumatoid Arthritis Specialized
Hospital, Shanghai, China
Ma et al. Diagnostic Pathology 2010, 5:20
http://www.diagnosticpathology.org/content/5/1/20
© 2010 Ma et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.thickness around the optic nerve (Figure 3 Part A and
B). The full-field electroretinography (FERG) amplitudes
were non-recordable (recorded according to the interna-
tional standard [7]). The multifocal electroretinography
(mfERG) were recorded binocularly with a stimulus size
of 61 hexagons using the RETIscan System (Roland
Consult, Wiesbaden, Germany) in accordance with the
guidelines of the International Society for Clinical
electrophysiology of Vision (ISCEV) [8]. The data of
amplitude and peak latency of N1 and P1 response from
ring 1 to 5 of both eyes were shown in Figure 4. The
results demonstrated reduced focal responses with a
decrease in amplitude (Figure 4 Part A and B), the
amplitude of N1 and P1 of ring 1,2,3,4,5 remarkably
diminished, and the peak latency of N1 and P1
responses were both delayed.
Figure 1 The ocular fundus photographs and fundus fluorescein angiography (FFA) of the two patients. A and B: the left eye of case 1;
C and D: the left eye of case 2. There were pigmentary deposits and atropy in the whole retina. The hyperfluorescence in FFA images enhanced
by time, without leakage.
Figure 2 The optical coherence tomography (OCT) scan of the two patients. A: severe macular thinning in Case 1. B: Irregular retinal
pigment epithelium (RPE) signal in Case 1. C: neurepithelium atropy in Case 2. D: Irregular RPE signal in Case 2.
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A 55-year-old woman had taken chloroquine for rheu-
matoid arthritis for more than 4 years, with an esti-
mated total dose of 365 g (250 mg daily). She first
presented with a history of gradually decreasing visual
acuity without any other symptoms approximately two
years earlier. The latest examination revealed that her
visual acuity was 30/200 OD and 60/200 OS, Goldmann
applanation intraocular pressure was normal (OD13
mmHg, OS12 mmHg), the center visual field was
severely damaged, and the Goldmann visual field
showed central scotoma in both eyes. Her ocular fundus
photograph also showed pigmentary deposits and atro-
phy, attenuation of the retinal artery, waxy pallor of the
optic disc, and retinal atrophy (Figure 1 Part C). Differ-
ing from Patient 1, FFA of Patient 2 showed marked
hyperfluorescence in the macular area with clear demar-
cations (Figure 1 Part D). Round-shaped blocked fluor-
escence was seen in the central fovea. OCT showed
retinal nerve fiber layer atrophy and irregular RPE sig-
nals (Figure 2 Part C and D), however, the central fovea
thickness was not decreased to as great an extent as
that observed in Patient 1. The RNFL thickness around
the optic nerve measured by OCT was normal, which
was also supported by the GDxVCC results (Figure 3
Part C and D). The FERG amplitudes were decreased in
both eyes, and the mfERG (with 61 stimuli) indicated
reduced focal responses with a decrease in amplitude
and prolonged peak latency of N1 and P1 responses in
both eyes, especially in the ring 1 and 2 (Figure 4 Part C
a n dD ) .T h ed a t ao fa m p l i t u d ea n dp e a kl a t e n c yo fN 1
and P1 response from ring 1 to 5 were shown in Figure
4 Part C and D.
Discussion
Chloroquine toxicity is not uncommon, especially in
patients receiving long-term therapy [1-3]. While hydro-
xychloroquine is now frequently prescribed instead of
chloroquine because of its higher therapeutic window,
its use has also been shown to cause retinal damage [4].
Histological analysis of human and animal retinas with
chloroquine toxicity has demonstrated the loss of
Figure 3 The retinal nerve fiber layer (RNFL) thickness image of GDxVCC around the optic nerve, the thickness values were normal.
A: the right eye of case 1. B: the left eye of case 1. C: the right eye of case 2. D: the left eye of case 2.
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Page 3 of 5Figure 4 Multifocal electroretinography (mfERG) of the two patients. A: the right eye of case 1. B: the left eye of case 1. C: the right eye of
case 2. D: the left eye of case 2. The images indicated reduced focal responses with a decrease in amplitude and prolonged peak latency of N1
and P1 responses in both eyes. In case 1, the amplitude of N1 and P1 of ring 1,2,3,4,5 remarkably diminished, and the peak latency of N1 and P1
responses were both delayed. In case 2, there were a decrease in amplitude and prolonged peak latency of N1 and P1 responses in both eyes,
especially in the ring 1 and 2.
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result from inhibition of lysosomal phospholipases and
protein synthesis. However, the initial retinal damage is
thought to occur in ganglion cells [7].
In contrast to the usual clinical observations, there was
no major pigment atrophy ring with a clarified boundary
around the central fovea (making the characteristic bulls-
eye) in the FFA image from our patients. However, we did
observe a marked hyperfluorescence in the macular area,
possibly due to RPE atrophy. Although it is frequently
used in the clinic, full-field ERG may not be a reliable
method for identifying early chloroquine retinopathy [3].
In our cases, because the two patients had severe retinopa-
thy, the FERG amplitudes were non-recordable. Therefore,
F-ERG analysis may have limited value in the diagnosis of
early chloroquine retinopathy, because the toxicity is loca-
lized and a full field analysis may not be sensitive to loca-
lized retinal toxocity in early disease.
It has been suggested that mfERG is a more sensitive
method that can be used to detect chloroquine retinopa-
thy [9]. For example, in one study, even though clinical
examinations found no abnormalities in a patient with a
long history of hydroxychloroquine use [3], mfERG
showed an absence of foveal rings and the presence of
pericentral isoelectric waveforms. In our current report,
the patients had severely damaged visual acuity and cen-
ter visual field loss, mfERG showed a reduction in focal
responses and a delay in the peak latency.
There have been some reports in which OCT was
used in the detection of chloroquine and hydroxychloro-
quine-induced retinopathy [10]. In our cases, not only
the “bulls-eye” was shown in the fundus photograph,
but also the proliferation-atrophy-proliferation changes
o ft h eR P Ei nt h em a c u l a ra r e aw e r ed e t e c t e db yO C T .
Confirming these results, the RNFL thickness measured
by GDx (GDx Nerve Fiber Analyzer (NFA) is a relatively
new and improved technology that uses scanning laser
polarimetry (SLP)) was within the normal range in our
patients, this result was different from the conclusions
of some other reports. For example, Bonanomi et al [11]
reported that mean RNFL thickness measured by
GDxFCC from patients using chloroquine were signifi-
cantly different from the control group in all regions
around the optic disc. Possible explanation for this dif-
f e r e n c em i g h tb et h a tt h ed a m a g eo fr e t i n ai ns o m e
patients taking chloroquine distributed mainly in the
macula area, while the RNFL thickness around the optic
disc remained normal.
To the best of our knowledge, this is the first report
describing the findings of FFA, OCT, GDxVCC NFA,
FERG, mfERG and visual field examinations in the same
patients with chloroquine retinopathy. While the fundus
pictures from the two patients are similar, there are dif-
ferences in their macular thickness. Thus, given the
differences found using the various methods and instru-
ments, and the well-documented weaknesses of the var-
ious techniques, it is evident that multiple analyses are
helpful for better understanding of chloroquine
retinopathy.
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